Effects of interferon-beta on microglial functions as inflammatory and antigen presenting cells in the central

Jun Kawanokuchi1, Tetsuya Mizuno, Hideki Kato

  • 1Department of Neuroimmunology, Research Institute of Environmental Medicine, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan.

Neuropharmacology
|March 5, 2004
PubMed

Insights

Interferon-beta (IFNbeta) may suppress early multiple sclerosis (MS) by inhibiting microglial antigen presentation. However, it can worsen later inflammatory phases by increasing demyelination mediators, suggesting co-treatments to mitigate side effects.

Area of Science:

  • Neuroimmunology
  • Cellular immunology

Background:

  • Interferon-beta (IFNbeta) is a treatment for relapsing-remitting multiple sclerosis (MS).
  • The precise mechanisms of IFNbeta's therapeutic effects in MS remain unclear.
  • Microglia play dual roles in MS as antigen-presenting cells and effector cells in inflammatory demyelination.

Purpose of the Study:

  • To investigate the impact of IFNbeta on microglial functions in the context of multiple sclerosis.
  • To elucidate how IFNbeta influences antigen presentation and inflammatory mediator production by microglia.

Main Methods:

  • Assessed IFNbeta's effects on microglial expression of MHC class II and B7-1.
  • Measured IFNbeta's impact on microglial IL-12 production.
  • Evaluated IFNbeta's influence on the differentiation of myelin oligodendrocyte glycoprotein (MOG)-sensitized T cells.
  • Analyzed the production of inflammatory mediators (TNF-alpha, IL-1beta, IL-6, NO) by microglia.
  • Investigated the effect of a phosphodiesterase inhibitor on IFNbeta-induced mediator production.

Main Results:

  • IFNbeta significantly suppressed MHC class II and B7-1 expression on microglia.
  • IFNbeta inhibited microglial IL-12 production and T helper 1 cell differentiation.
  • IFNbeta dose-dependently enhanced the production of pro-inflammatory mediators (TNF-alpha, IL-1beta, IL-6, NO) involved in demyelination.
  • A phosphodiesterase inhibitor effectively suppressed the upregulation of these inflammatory mediators.

Conclusions:

  • IFNbeta may exert beneficial effects during the induction phase of MS by impairing microglial antigen presentation.
  • IFNbeta might exacerbate the effector phase of MS by promoting inflammatory demyelination.
  • Elevated pro-inflammatory cytokines may contribute to IFNbeta side effects.
  • Co-treatment with phosphodiesterase inhibitors could potentially reduce IFNbeta-associated side effects.

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...